https://www.expresspharma.in/covid19-updates/remdesivir-in-india-an-unfolding-story/ https://www.expresspharma.in/covid19-updates/remdesivir-in-i... > To expand

https://www.expresspharma.in/covid19-updates/remdesivir-in-india-an-unfolding-story/ https://www.expresspharma.in/covid19-updates/remdesivir-in-i... > To expand the supply of remdesivir across the globe, Gilead Sciences has signed non-exclusive voluntary licensing agreements with four Indian generic pharma manufacturers, namely; Cipla, Hetero Labs, Jubilant Lifesciences and Mylan as well as a Pakistani firm, Ferozsons Laboratories to manufacture and distribute remdesivir in 127 countries.